Endocrine oncology

Prevalence and genetics of “de novo” MEN2 syndromes

J Clin Endocrinol MetabPublished Genetic study

Authors' conclusion

The prevalence of de novo hereditary MEN2 syndromes was approximately 16%, including MEN2B, and around 9% for other phenotypes. All de novo cases were of paternal origin and likely resulted from an acquired alteration in sperm DNA. The possible role of advanced paternal age in promoting de novo mutations could not be ruled out.

Study context

Population
Families with hereditary medullary thyroid carcinoma (MTC); 152 of 215 families selected
Participants
152 families
Outcome
Prevalence of de novo MEN2 syndromes and parental origin of the RET de novo mutation

Main finding

As reported in the abstract

De novo RET mutation in index case
Families in which the index case had a de novo mutation
24 of 152 (15.78%)
Mutation on the paternal allele (SNP analysis)
all cases

Further findings

Paternal age at conception

Mean age of fathers at conception relatively advanced in some cases but not all

Original publication

Prevalence and genetics of “de novo” MEN2 syndromes. J Clin Endocrinol Metab. Published 25 March 2025. doi:10.1210/clinem/dgaf171

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.